ClearNote Health, Inc.
The key to managing cancer is early detection. ClearNote Health makes this possible by finding signals of cancer in the blood early
Funding history
About ClearNote Health, Inc.
How much funding has ClearNote Health, Inc. raised?
ClearNote Health, Inc. has raised $21.8M in total funding. The most recent round was Series D.
Where is ClearNote Health, Inc. headquartered?
ClearNote Health, Inc. is headquartered in San Diego, CA.
What does ClearNote Health, Inc. do?
The key to managing cancer is early detection. ClearNote Health makes this possible by finding signals of cancer in the blood early
What problem does ClearNote Health, Inc. solve?
Cancers with high mortality rates often have no or very limited options for early detection, reducing the chance treatment can be effective.
What's ClearNote Health, Inc.'s solution?
Offers blood-based DNA tests (the Avantect line, including pancreatic and ovarian cancer tests) built on its proprietary Virtuoso epigenomics platform to find early signals of cancer.
What makes ClearNote Health, Inc. different?
Uses a proprietary epigenomic, cell-free DNA platform (Virtuoso) that measures active disease biology, and focuses specifically on single-disease and targeted multi-cancer panels for cancers that currently have limited detection options.
What makes ClearNote Health, Inc. notable?
Has raised more than $185 million in total funding; its 2026 Series D round was led by founding investor Mattias Westman, founder of emerging-markets investment firm Prosperity Capital Management.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.